Biotalys
EMEA
Ghent
,
Belgium
Scaleup
FOUNDED
2013
HEADCOUNT
21-100
FUNDING
Public
Keywords:
crop_protection, antibodies
BUSINESS
Develops protein-based biocontrol products (Agrobodies) for crop protection against pests and diseases as alternatives to chemical pesticides. Biotalys was founded in 2013 as a spin-off from VIB (Flanders Institute for Biotechnology), is headquartered in Ghent, Belgium, and listed on Euronext Brussels since July 2021. Its lead product EVOCA is a protein-based biofungicide targeting Botrytis and powdery mildew in grapevines, with the company currently advancing its second-generation AGROBODY 2.0 platform
BIOTECH INVOLVEMENT
Core; Ghent-based VIB spin-off (2013) developing recombinant antibody-derived crop-protection proteins (Agrobodies) as alternatives to chemical pesticides; protein engineering and recombinant production are entirely central.
TECHNOLOGY PLATFORM
Protein engineering (Agrobody platform)
PRIMARY PRODUCTS
Protein-based biocontrol pipeline (e.g., EVOCA and follow-on products)